Maximize the Impact of Your Metabolomics Data:
Drive Cutting Edge Metabolism Research
We enable metabolism research from bench to population-scale to unravel patient phenotypes and cellular physiology with unprecedented detail.
General Metabolics’ proprietary technology platform for metabolomics is uniquely suited for analyzing large-scale biological and clinical data sets.

One Partner, Multiple Tools
Applying the right tool from exploratory to focused inquiry.

Interactive Data Analysis
Including differential analysis, pathway enrichment etc,.

Integrated multi-omics
Enabling systems-level insight, and new links to genomic features.

Ultra-high throughput
Providing acquisition of up to 1,000 metabolite profiles in a single day.

Automated Data Pipelines
Creating Bio/Pharma informatics for any researcher.

Rapid Turnaround
Delivering data & interpretation in less than two weeks.
We collaborate with industrial and academic researchers to deliver ultra high-throughput metabolite analysis with unprecedented speed and unlimited scale.
GMet enables metabolomics to function at the speed and scale of the other tools of life science. High throughput data acquisition and automated data processing are coupled to an integrated software ecosystem to rapidly deliver biological analysis and insight. Our suite of capabilities include untargeted metabolomics, focused inquiry with LCMS/MS, lipidomics, network-based integrated-omics, as well as interactive data analysis tools. Automated data pipelines and informatics support rapid time to insight at any experimental scale with data delivery in less than 2 weeks.
At General Metabolics we provide a full suite of metabolomics capabilities that enable you to make metabolomics a central part of ongoing research, including untargeted metabolomics, focused inquiry with LCMS/MS, lipidomics, isotopic label tracing, network-based integrated-omics, as well as interactive data analysis tools. These tools have helped our clients accelerate therapeutics development, pathway engineering, biomarker discovery and mechanistic cellular research.
We handle studies from bench to population scale.
NEWS & PUBLICATIONS



